Nasopharyngeal Carcinoma Overview

Save information for later
Sign Up

Learn About Nasopharyngeal Carcinoma

What is the definition of Nasopharyngeal Carcinoma?
Nasopharyngeal carcinoma (NPC) is a tumor arising from the epithelial cells that cover the surface and line the nasopharynx.
What are the alternative names for Nasopharyngeal Carcinoma?
  • Nasopharyngeal carcinoma
  • Nasopharyngeal Cancer
Who are the top Nasopharyngeal Carcinoma Local Doctors?
Melvin K. Chua
Elite in Nasopharyngeal Carcinoma
Melvin K. Chua
Elite in Nasopharyngeal Carcinoma
Melvin K. Chua
Department Of Head And Neck Surgery, 
Singapore, SG 

Melvin Chua practices in Singapore, Singapore. Mr. Chua is rated as an Elite expert by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Prostate Cancer, Mononucleosis, Prostatectomy, and Orchiectomy.

Paolo Bossi
Elite in Nasopharyngeal Carcinoma
Paolo Bossi
Elite in Nasopharyngeal Carcinoma
Paolo Bossi

ASST Spedali Civili Di Brescia

Brescia, IT 

Paolo Bossi practices in Brescia, Italy. Mr. Bossi is rated as an Elite expert by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Nasopharyngeal Carcinoma, Adenoid Cystic Carcinoma, Laryngectomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Joseph T. Wee
Elite in Nasopharyngeal Carcinoma
Joseph T. Wee
Elite in Nasopharyngeal Carcinoma
Joseph T. Wee
30 Hospital Blvd, 
Singapore, SG 

Joseph Wee practices in Singapore, Singapore. Mr. Wee is rated as an Elite expert by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Cerebral Hypoxia, Mononucleosis, and Head and Neck Squamous Cell Carcinoma (HNSCC).

View All Doctors
What are the latest Nasopharyngeal Carcinoma Clinical Trials?
Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Procedure, Biological, Drug
Study Phase: Phase 2

Summary: This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to other places in the body (metastatic), or for which no treatment is currently available (incurable). Immunotherapy with mo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
Enrollment Status: Recruiting
Publish Date: October 10, 2025
Intervention Type: Biological, Procedure, Drug, Other, Radiation
Study Phase: Phase 2

Summary: This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, wo...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center